Juniper Publishers : A possible Molecular Mechanism of Adenomyosis
JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S HEALTH
Journal of Gynecology and Women’s Health-Juniper Publishers
Authored by Guoyun Wang*
Mini Review
Adenomyosis, an estrogen-dependent inflammatory disease, is defined as the presence of endometrial glands and stroma deep within the myometrium [1]. The main clinical features of adenomyosis are dysmenorrhea and menorrhagia, which are significantly associated with peritoneal endometriosis in infertile patients at reproductive age [2,3]. The only difference between adenomyosis and endometriosis is the site of endometriotic tissues, that is, inside or outside the uterus [4]. Thus, knowledge on the endometriotic cell origin is indispensable for the development of preventive and targeted treatment strategies for adenomyosis. The most widely accepted theory on the pathogenesis of adenomyosis is the down growth and invagination of the endometrium into the myometrium [5]. However, the possible mechanism of gland invagination from the endometrium deep into the underlying myometrium is unknown.
Epithelial mesenchymal transition (EMT) and its converse, mesenchymal epithelial transition (MET), are concepts defined decades ago [6]. Once epithelial cells become competent to respond to EMT-inducing signals, these signals can promote the disruption of the intercellular adhesion complexes and the loss of the apicobasal polarity of the epithelial cells, a prime feature crucial for cells to leave the epithelium and achieve migration potentiality [7]. Many studies indicated that EMT is a crucial process in adenomyosis and endometriosis lesions [8,9], and the endometrium and inner myometrium are closely apposed without any intervening basement membrane; thus, EMT events might occur here.
Macrophages have been known to play important roles in the adenomyosis process [4]. One study reported an increased stromal macrophage population in the functional layer of the endometrium in patients experiencing diffuse and focal adenomyosis [10]. Another study indicated that, after treating adenomyosis patients with the gonadotrophin releasing hormone (GnRH) agonist, the infiltration of CD68-positive macrophages is significantly decreased in the endometrium of adenomyotic women [11].
Abnormal levels of macrophages, which are important components of immune cells, have been largely reported in adenomyosis [12]. Increased knowledge on the immune aspects of the pathogenesis of adenomyosis is needed for this debilitating condition. To our knowledge, macrophages, which play important roles in innate and acquired immunity, together with natural killer cells and cytotoxic T-lymphocytes in healthy women, can destroy misplaced endometrial cells [13]. The EMT process induced by macrophages has been investigated systematically in tissue repair, remodeling, fibrosis [14], and tumor progression [15]. Alternatively activated (M2) macrophages are the major type associated with the tumor EMT process. Similar to tumor progression, adenomyosis also exhibits the EMT process.
Given that macrophages and EMT are all involved in the adenomyosis process, and the definite mechanism by which macrophages promote the development of adenomyosis is vague, we presumed that macrophages may induce endometrial epithelial cells to undergo EMT, because macrophages can induce EMT in many other diseases. Thus, EMT induced by macrophages might be an effective molecular mechanism to promote adenomyosis.
Adenomyosis, an estrogen-dependent inflammatory disease, is defined as the presence of endometrial glands and stroma deep within the myometrium [1]. The main clinical features of adenomyosis are dysmenorrhea and menorrhagia, which are significantly associated with peritoneal endometriosis in infertile patients at reproductive age [2,3]. The only difference between adenomyosis and endometriosis is the site of endometriotic tissues, that is, inside or outside the uterus [4]. Thus, knowledge on the endometriotic cell origin is indispensable for the development of preventive and targeted treatment strategies for adenomyosis. The most widely accepted theory on the pathogenesis of adenomyosis is the down growth and invagination of the endometrium into the myometrium [5]. However, the possible mechanism of gland invagination from the endometrium deep into the underlying myometrium is unknown.
Epithelial mesenchymal transition (EMT) and its converse, mesenchymal epithelial transition (MET), are concepts defined decades ago [6]. Once epithelial cells become competent to respond to EMT-inducing signals, these signals can promote the disruption of the intercellular adhesion complexes and the loss of the apicobasal polarity of the epithelial cells, a prime feature crucial for cells to leave the epithelium and achieve migration potentiality [7]. Many studies indicated that EMT is a crucial process in adenomyosis and endometriosis lesions [8,9], and the endometrium and inner myometrium are closely apposed without any intervening basement membrane; thus, EMT events might occur here.
Macrophages have been known to play important roles in the adenomyosis process [4]. One study reported an increased stromal macrophage population in the functional layer of the endometrium in patients experiencing diffuse and focal adenomyosis [10]. Another study indicated that, after treating adenomyosis patients with the gonadotrophin releasing hormone (GnRH) agonist, the infiltration of CD68-positive macrophages is significantly decreased in the endometrium of adenomyotic women [11].
Abnormal levels of macrophages, which are important components of immune cells, have been largely reported in adenomyosis [12]. Increased knowledge on the immune aspects of the pathogenesis of adenomyosis is needed for this debilitating condition. To our knowledge, macrophages, which play important roles in innate and acquired immunity, together with natural killer cells and cytotoxic T-lymphocytes in healthy women, can destroy misplaced endometrial cells [13]. The EMT process induced by macrophages has been investigated systematically in tissue repair, remodeling, fibrosis [14], and tumor progression [15]. Alternatively activated (M2) macrophages are the major type associated with the tumor EMT process. Similar to tumor progression, adenomyosis also exhibits the EMT process.
Given that macrophages and EMT are all involved in the adenomyosis process, and the definite mechanism by which macrophages promote the development of adenomyosis is vague, we presumed that macrophages may induce endometrial epithelial cells to undergo EMT, because macrophages can induce EMT in many other diseases. Thus, EMT induced by macrophages might be an effective molecular mechanism to promote adenomyosis.
For more open access journals in JuniperPublishers please click on: https://juniperpublishers.com/
For more articles on Gynecology and Women’s Health please click on: https://juniperpublishers.com/jgwh/
To read more......Fulltext in Gynecology and Women’s Health in Juniper Publishers
https://juniperpublishers.business.site/
Comments
Post a Comment